Case study

BASF Pharma Research and Development

Transforming a multi-billion dollar business

BASF Pharma's Accelerating Clinical Development (ACD) programme was launched in partnership with PA Consulting Group, with twin aims: to cut clinical drug development times by 40 per cent and to achieve effective globalisation of processes. PA was chosen because of our industry expertise, coupled with our pragmatic approach to developing solutions. PA demonstrated a deep understanding of cultural sensitivities and the complexities of driving through major change programmes.

“Before ACD, we developed drugs below the industry average. Now our top development project time lines are comparable to those of the Pfizers of the world.” Professor Erich Schlick , Head of Knoll AG